Literature DB >> 12010804

Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1.

Quansheng Zhou1, Ji Zhao, Therese Wiedmer, Peter J Sims.   

Abstract

Phospholipid scramblase 1 (PLSCR1) is an endofacial plasma membrane protein proposed to participate in transbilayer movement of phosphatidylserine and other phospholipids. In addition to its putative role in the reorganization of plasma membrane phospholipids, PLSCR1 is a substrate of intracellular kinases that imply its possible participation in diverse signaling pathways underlying proliferation, differentiation, or apoptosis. Because PLSCR1 is prominently expressed in a variety of blood cells, we evaluated PLSCR activity in platelets and erythrocytes, and cytokine-dependent growth of hematopoietic precursor cells, of PLSCR1 knock-out mice. Adult PLSCR1(-/-) mice showed no obvious hematologic or hemostatic abnormality, and blood cells from these animals normally mobilized phosphatidylserine to the cell surface upon stimulation. Whereas blood cell counts in adult PLSCR1(-/-) mice were normal, in both fetus and newborn animals neutrophil counts were significantly depressed relative to age-matched wild type (WT). Furthermore, when compared with WT, hematopoietic precursor cells from PLSCR1(-/-) mice showed defective colony formation and impaired differentiation to mature granulocytes as stimulated by stem cell factor and granulocyte colony-stimulating factor (G-CSF). By contrast, PLSCR1(-/-) cells showed normal colony formation stimulated by interleukin-3 or granulocyte-macrophage CSF, and expansion of megakaryocytic and erythroid progenitors by thrombopoietin or erythropoietin was unaffected. Stem cell factor and G-CSF were also found to induce marked increases in PLSCR1 levels in WT cells. Consistent with in vitro assays, PLSCR1(-/-) mice treated with G-CSF showed less than 50% of the granulocytosis observed in identically treated WT mice. These data provide direct evidence that PLSCR1 functionally contributes to cytokine-regulated cell proliferation and differentiation and suggest it is required for normal myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010804     DOI: 10.1182/blood-2001-12-0271

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Phospholipid scramblase 1 potentiates the antiviral activity of interferon.

Authors:  Beihua Dong; Quansheng Zhou; Ji Zhao; Aimin Zhou; Ronald N Harty; Santanu Bose; Amiya Banerjee; Roger Slee; Jeanna Guenther; Bryan R G Williams; Therese Wiedmer; Peter J Sims; Robert H Silverman
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Inhibition of erythrocyte "apoptosis" by catecholamines.

Authors:  Philipp A Lang; Daniela S Kempe; Ahmad Akel; Barbara A Klarl; Kerstin Eisele; Marlies Podolski; Tobias Hermle; Olivier M Niemoeller; Philipp Attanasio; Stephan M Huber; Thomas Wieder; Florian Lang; Christophe Duranton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-10-25       Impact factor: 3.000

3.  Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members.

Authors:  Jun Suzuki; Toshihiro Fujii; Takeshi Imao; Kenji Ishihara; Hiroshi Kuba; Shigekazu Nagata
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

4.  Phospholipid scramblase 1 mediates type i interferon-induced protection against staphylococcal α-toxin.

Authors:  Miroslaw Lizak; Timur O Yarovinsky
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

5.  Phospholipid scramblase-1-induced lipid reorganization regulates compensatory endocytosis in neuroendocrine cells.

Authors:  Stéphane Ory; Mara Ceridono; Fanny Momboisse; Sébastien Houy; Sylvette Chasserot-Golaz; Dimitri Heintz; Valérie Calco; Anne-Marie Haeberlé; Flor A Espinoza; Peter J Sims; Yannick Bailly; Marie-France Bader; Stéphane Gasman
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

6.  Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).

Authors:  Therese Wiedmer; Ji Zhao; Lilin Li; Quansheng Zhou; Andrea Hevener; Jerrold M Olefsky; Linda K Curtiss; Peter J Sims
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

7.  Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.

Authors:  Rajas V Warke; Kris Xhaja; Katherine J Martin; Marcia F Fournier; Sunil K Shaw; Nathaly Brizuela; Norma de Bosch; David Lapointe; Francis A Ennis; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 8.  The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.

Authors:  Bengt Fadeel; Ding Xue
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

Review 9.  Phosphatidylserine targeting for diagnosis and treatment of human diseases.

Authors:  Kristof Schutters; Chris Reutelingsperger
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

10.  Phospholipid scramblases and Tubby-like proteins belong to a new superfamily of membrane tethered transcription factors.

Authors:  Alex Bateman; Robert D Finn; Peter J Sims; Therese Wiedmer; Andreas Biegert; Johannes Söding
Journal:  Bioinformatics       Date:  2008-11-13       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.